SWEDEN: REMYNIL BY SANOCHEMIA
Article Abstract:
The Austrian company Sanochemia Pharmazeutika AG is to file for European approval for Remynil. The pharmaceutical for the treatment of Alzheimer's disease, which contains galantamine, has been approved in Sweden. Sanochemia's partners, Janssen-Cilag and Shire Pharmaceuticals Group plc will market the drug worldwide.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
SWITZERLAND/UK: ARES SERONO, BRITISH BIOTECH R&D
Article Abstract:
Ares Serono of Switzerland and British Biotech plc of Oxford have signed an exclusive cooperation agreement concerning research, development and commercialisation of metal enzyme inhibitors for the treatment of severe inflammatory diseases. British Biotech is starting clinical tests of two inhibitors. Ares Serono has secured an option for the exclusive rights to the two inhibitors, which might be used in the treatment of multiple sclerosis.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
AUSTRIA: SANOCHEMIA BOOSTS SYNTHESIS
Article Abstract:
The Austrian company Sanochemia Pharmazeutika is quadrupling active agent synthesis capacity at its plant in Neufeld to 12 tonnes per year. The investment amounts to EUR 2.9mn. The facility is used also for the production of the Alzheimer treatment Nivalin.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2000
User Contributions:
Comment about this article or add new information about this topic: